Condensed Consolidated Interim Balance Sheets - USD ($)	Sep. 30, 2025	Mar. 31, 2025
CURRENT ASSETS
Cash	$ 308,460	$ 365,145
Accounts receivable, net	2,099,065	1,658,772
Inventory [Note 3]	2,256,289	1,555,385
Deposits and other receivables	872,420	1,059,990
Total current assets	5,536,234	4,639,292
Deposits and other receivables [Note 12]	109,297	109,297
Long-term accounts receivable	83,939	70,713
Property and equipment [Note 13]	6,622	9,599
Operating right of use assets [Note 12]	586,680	812,053
TOTAL ASSETS	6,322,772	5,640,954
CURRENT LIABILITIES
Accounts payable and accrued liabilities [Note 4]	7,908,201	7,661,924
Convertible promissory notes and short term loans [Note 5]	10,394,614	9,618,738
Term loan, current	2,400,000	2,400,000
Derivative liabilities [Note 8]	443,583	424,200
Advance from customers	1,895,920
Operating lease obligations, current [Note 10]	571,706	531,286
Total current liabilities	23,614,024	20,636,148
Federally guaranteed loans [Note 7]	870,800	870,800
Term loan [Note 6]	12,015,626	12,271,559
Derivative liabilities [Note 8]	1,382,103	1,478,717
Operating lease obligations	102,307	397,830
TOTAL LIABILITIES	37,984,860	35,655,054
STOCKHOLDERS’ EQUITY (DEFICIENCY)
Series A Preferred stock, $0.001 par value, 20,000 shares authorized as at September 30, 2025 and March 31, 2025, respectively, 201 and 201 shares issued and outstanding as at September 30, 2025 and as at March 31, 2025, respectively [Note 9]	1	1
Common stock, $0.001 par value, 125,000,000 shares authorized as at September 30, 2025 and March 31, 2025, respectively. Issued and outstanding common shares: 26,791,608 and 26,081,295 as at September 30, 2025 and March 31, 2025, respectively, and exchangeable shares of 160,672 outstanding as at September 30, 2025 and March 31, 2025, respectively [Note 9]	26,953	26,243
Shares to be issued 581,599 and 324,276 shares of common stock as at September 30, 2025 and March 31, 2025, respectively [Note 9]	284,244	284,244
Additional paid-in-capital	107,278,101	107,123,300
Accumulated other comprehensive loss	(33,276)	(6,393)
Accumulated deficit	(140,968,401)	(139,441,785)
Total stockholders’ equity (deficiency)	(33,412,378)	(32,014,390)
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY	6,322,772	5,640,954
Series B Convertible Redeemable Preferred Stock [Member]
Mezzanine Equity
Series B Convertible Redeemable preferred stock, $0.001 par value, 600 shares authorized as of September 30, 2025 and March 31, 2025, respectively, 360 and 385 shares issued and outstanding as of September 30, 2025 and March 31, 2025, respectively [Note 9]	1,750,290	2,000,290
Series A Preferred Stock [Member]
STOCKHOLDERS’ EQUITY (DEFICIENCY)
Series A Preferred stock, $0.001 par value, 20,000 shares authorized as at September 30, 2025 and March 31, 2025, respectively, 201 and 201 shares issued and outstanding as at September 30, 2025 and as at March 31, 2025, respectively [Note 9]